Purinergic receptors (P2XRs) activate and desensitize in response to the binding of extracellular nucleotides in a receptor-and ligand-specific manner, but the structural bases of their ligand preferences and channel kinetics have been incompletely characterized. Here we tested the hypothesis that affinity of agonists for binding domain accounts for a ligand-specific desensitization pattern. We generated chimeras using receptors with variable sensitivity to ATP in order: P2X 4 R > P2X 2a R Purinergic receptors (P2XRs) 1 are a family of ligand-gated receptor channels that open in response to the binding of extracellular ATP. Like other ligand-gated receptor channels, P2XRs also become refractory to the stimulus during the sustained agonist occupancy. This process, called desensitization, was initially characterized in acetylcholine receptors by Katz and Thesleff (1) and occurs because receptors enter stable desensitized states in which ion permeation is blocked or attenuated although ligand remains bound. Significant progress has been made recently in characterizing the ectodomain architecture of other ligand-gated receptor channels and the relationship between ligand-binding domain occupancy and receptor activity (2-4). However, the boundaries of the ectodomain and ATP-binding domain of P2XRs and the molecular mechanisms of transduction of information from ligandbinding domain to the pore of channels are largely unknown (5).
Purinergic receptors (P2XRs) activate and desensitize in response to the binding of extracellular nucleotides in a receptor-and ligand-specific manner, but the structural bases of their ligand preferences and channel kinetics have been incompletely characterized. Here we tested the hypothesis that affinity of agonists for binding domain accounts for a ligand-specific desensitization pattern. We generated chimeras using receptors with variable sensitivity to ATP in order: P2X 4 Purinergic receptors (P2XRs) 1 are a family of ligand-gated receptor channels that open in response to the binding of extracellular ATP. Like other ligand-gated receptor channels, P2XRs also become refractory to the stimulus during the sustained agonist occupancy. This process, called desensitization, was initially characterized in acetylcholine receptors by Katz and Thesleff (1) and occurs because receptors enter stable desensitized states in which ion permeation is blocked or attenuated although ligand remains bound. Significant progress has been made recently in characterizing the ectodomain architecture of other ligand-gated receptor channels and the relationship between ligand-binding domain occupancy and receptor activity (2) (3) (4) . However, the boundaries of the ectodomain and ATP-binding domain of P2XRs and the molecular mechanisms of transduction of information from ligandbinding domain to the pore of channels are largely unknown (5) .
Modification at the triphosphate moiety of ATP served well in identification of native P2XR subtypes and provided useful information about the putative ligand-binding domain. For example, the substitution of bridging oxygen between ␣-and ␤-phosphorus with a methylene group resulted in a ligand, called ␣␤-meATP, which is a high potency agonist for P2X 1 R and P2X 3 R, low potency agonist for P2X 2 R, and partial agonist for P2X 4 R (6). High sensitivity of P2X 3 R to ␣␤-meATP can be transferred to P2X 2a R and P2X 2b R subtypes by generating the extracellular chimeras having the ectodomain of the P2X 3 subunit in the P2X 2 -based backbone (7) . These chimeras also exhibited enhanced rates of desensitization (7, 8) . Within this region, single residue mutation studies have identified positively charged Lys 68 , Lys 70 , and Lys 309 of P2X 1 R and the corresponding Lys 69 and Lys 71 of P2X 2 R as contributing to the ATP-binding site and control of rate of receptor desensitization (9, 10) . In general agreement with these observations, the N-terminal half of the P2X 3 ectodomain, from Val 60 to Arg 180 , is necessary for high ␣␤-meATP sensitivity of the receptor. The attempt to further narrow this region was obstructed, indicating that the ectodomain is sensitive to modification by sitedirected mutagenesis (7) .
P2XRs activate and desensitize in a receptor-and ligandspecific manner. When stimulated with ATP, P2X 1 R and P2X 3 R desensitize very rapidly (in an ms time scale), P2X 4 R and P2X 6 R desensitize with a moderate rate (within a few seconds), and P2X 2 R, P2X 5 R, and P2X 7 R show little or no desensitization (11, 12) . Two main hypotheses emerged from previous work on desensitization of P2XRs, one based on the structure of channels and the other based on the actions of intracellular messengers. Heteromultimerization results in P2XRs that desensitize with different kinetics from those seen in cells expressing homomeric receptors (13) (14) (15) . The site-directed mutagenesis experiments indicated the relevance of Cterminal structure on the desensitization of P2XR (15) (16) (17) (18) (19) , as well as the relevance of a highly conserved N-terminal site for protein kinase C in functional desensitization of receptors (19 -21) . Phosphorylation of a protein kinase A site in C-terminal of P2X 2a R may also participate in receptor desensitization (22) . In parallel to other ligand-gated receptor channels (2, (23) (24) (25) (26) (27) (28) , the ligand-binding domain of P2XRs may also contribute to the control of rates of desensitization (7, 8) .
Here, we extended investigations on the relevance of the ectodomain structure on ligand selectivity and the pattern of P2XR desensitization. Experiments were done with wild-type P2X 2a R, P2X 2b R, and P2X 4 R and chimeric P2X 2a ϩ X 4 R and P2X 2b ϩ X 4 R containing the ectodomain sequence of P2X 4 R instead of the corresponding P2X 2 R sequence. The reverse P2X 4 ϩ X 2 R chimera was also constructed, as well as the P2X 4 ϩ X 7 R chimera containing the ectodomain sequence of P2X 7 R. To clarify the possible interaction between the ectodomain and C-terminal domain in control of agonist specificity and receptor activity, we also constructed P2X 2a-6aa ϩ X 4 R mutant chimera containing the C-terminal 6-residue sequence of P2X 4 R instead of the corresponding sequence of P2X 2a ϩ X 4 R. Both whole-cell patch clamp current recordings and calcium measurements were used to estimate the activity of receptors in response to ATP, the native agonist for P2XRs, and two agonist analogs, BzATP and ␣␤-meATP. The results of these investigations clearly indicate the C-terminal-independent influence of the ectodomain structure on agonist potency and rate of P2XR desensitization. Mouse immortalized gonadotropin-releasing hormone-secreting cells (hereafter GT1 cells) and human embryonic kidney cells (hereafter HEK293 cells) were used in functional studies of wild-type and mutant P2XRs, as described previously (15) . GT1 cells were routinely maintained in Dulbecco's modified Eagle's medium/Ham's F12 medium (1:1) containing 10% (v/v) fetal bovine serum and 100 g/ml gentamicin (Invitrogen) in a water-saturated atmosphere of 5% CO 2 and 95% air at 37°C. HEK293 cells were cultured in minimum Eagle's medium supplemented with 10% horse serum and 100 g/ml gentamicin. Before the day of transfection, cells were plated on 25-mm poly-L-lysine (0.01% w/v; Sigma)-coated coverslips at a density of 0.75-1 ϫ 10 5 cells/35-mm dish. For each dish of cells, transient transfection of expression constructs was conducted using 1 g of DNA and 7 l of LipofectAMINE 2000 reagent (Invitrogen) in 3 ml of serum-free Opti-MEM. After 6 h of incubation, the transfection mixture was replaced with normal culture medium. Cells were subjected to experiments 24 -48 h after transfection.
MATERIALS AND METHODS

DNA
Calcium Measurements-Transfected GT1 cells were preloaded with 1 M Fura-2 acetoxymethyl ester (Fura-2/AM; Molecular Probes, Eugene, OR) for 60 min at room temperature in modified Krebs-Ringer buffer: 120 mM NaCl, 5 mM KCl, 1.2 mM CaCl 2 , 0.7 mM MgSO 4 , and 15 mM HEPES plus 1.8 g/liter glucose (pH 7.4). After dye loading, cells were incubated in Modified Krebs-Ringer buffer and kept in the dark for at least 30 min before single-cell [Ca 2ϩ ] i measurements. Coverslips with cells were mounted on the stage of an Axiovert 135 microscope (Carl Zeiss, Oberkochen, Germany) attached to the Attofluor digital fluorescence microscopy system (Atto Instruments, Rockville, MD). Cells were stimulated with various doses of agonists, the dynamic changes of [Ca 2ϩ ] i were examined under a ϫ40 oil immersion objective during exposure to alternating 340-and 380-nm light beams, and the intensity of light emission at 520 nm was measured. The ratio of light intensities, F 340 /F 380 , which reflects changes in [Ca 2ϩ ] i , was simultaneously followed in several single cells. GFP was used as a marker for cells with P2XR expression as described previously (15 (29) . ATP-induced currents were recorded using an Axopatch 200B patch clamp amplifier (Axon Instruments, Union City, CA) and were filtered at 2 kHz using a low pass Bessel filter. 40 -70% series resistance compensation was used. Patch electrodes, fabricated from borosilicate glass (type 1B150F-3; World Precision Instruments, Sarasota, FL) using a Flaming Brown horizontal puller (P-87; Sutter Instruments, Novato, CA), were heat-polished to a final tip resistance of 3-5 megaohms. All current records were captured and stored using the pClamp 8 software packages in conjunction with the Digidata 1322A A/D converter (Axon Instruments). Patch electrodes were filled with a solution containing 140 mM KCl, 0.5 mM CaCl 2 , 1 mM MgCl 2 , 5 mM EGTA, and 10 mM HEPES; the pH was adjusted with 1 M KOH to 7.2. The osmolarity of the internal solutions was 282-287 mosM. The bath solution contained 142 mM NaCl, 3 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES; the pH was adjusted to 7.3 with 1 M NaOH. The osmolarity of this solution was 285-295 mosM. A 3 M KCl agar bridge was placed between the bathing solution and the reference electrode. ATP was applied for 60 s using a fast gravity-driven microperfusion system (BPS-8, ALA Scientific Instruments, Westbury, NY). The application tip was routinely positioned about 500 m above the recorded cell. Less than 600 ms was required for complete exchange of solutions around the patched cells, as estimated from altered potassium current (10 -90% rise time). The time between each ATP application was about 10 min to allow recovery from receptor desensitization.
Calculations-The time course of the [Ca 2ϩ ] i was fitted to a single exponential function (ae Ϫktbϩb ) using GraphPad Prism (GraphPad Software, San Diego, CA) to generate the rates of signaling desensitization (k) and half-times of decay ( ϭ ln2/k). The time courses of currents evoked by sustained ATP stimulation were fitted to a single exponential function using the pClamp 8 program (Axon Instruments). Significant differences, with p Ͻ 0.05, were determined by one-way analysis of variance with Newman-Keuls multiple comparison test. Concentrationresponse relationships were fitted to a four-parameter logistic equation using a non-linear curve-fitting program, which derives 50% efficient concentrations (EC 50 ) and 50% desensitizing concentrations (DC 50 ) (Kaleidagraph, Synergy Software, Reading, PA).
RESULTS
Characterization of Wild-type and Chimeric P2XRs-When
expressed in GT1 cells under identical experimental conditions, parental receptors P2X 2a R, P2X 2b R, and P2X 4 R responded to ATP, BzATP, and ␣␤-meATP stimulation with a rapid rise in [Ca 2ϩ ] i followed by a gradual decline toward steady plateau levels. In accordance with previously published data (8, 30) , in all agonist concentrations studied, the peak [Ca 2ϩ ] i responses were comparable in P2X 2a R-and P2X 2b R-expressing cells. Fig.  1A illustrates the concentration dependence of three agonists on the peak amplitude of [Ca 2ϩ ] i responses for both receptor subtypes combined. The calculated EC 50 values (Fig. 1 , dotted vertical lines) were in general agreement with the data in the literature (6): ATP was the most potent agonist for P2X 2 Rs, followed by BzATP, whereas ␣␤-meATP acted as a low potency agonist.
On the other hand, the estimated EC 50 values for ATP, BzATP, and ␣␤-meATP in GT1 cells expressing rat P2X 4 R (Fig.  1B) differed significantly from previously published data (reviewed in Ref. 6 ). In our experiments, ATP was a highly potent agonist for these receptors, with an EC 50 of about 1 M, and the calculated EC 50 for BzATP was 2.5 M as compared with Ͼ500 M reported in other expression systems. At supramaximal concentrations, the peak amplitudes of ATP-and BzATP-induced [Ca 2ϩ ] i responses in P2X 4 R-expressing cells were about 40% of those observed in P2X 2 R-expressing cells, whereas the peak amplitudes of current responses were comparable (Fig. 1) .
␣␤-meATP-induced peak current/ [Ca 2ϩ ] i responses were 44% as compared with those in ATP-and BzATP-stimulated cells, consistent with the partial agonist action of this ATP analog observed in other expression systems (31) , but the calculated EC 50 was 4 M (Fig. 1B) .
The P2X 2a ϩ X 4 R and P2X 2b ϩ X 4 R chimeras having the ectodomain of P2X 4 R in the backbone of P2X 2a R and P2X 2b R, respectively, were functional and responded to three agonists in a concentration-dependent manner with highly comparable peak amplitudes. Fig. 1C illustrates the combined results for both receptors. Chimeric receptors differed from parental receptors in two respects. First, although the structure of the pore was not altered, the peak amplitudes of [Ca 2ϩ ] i responses in chimeric receptors were 80% of those observed in P2X 2a Rand P2X 2b R-expressing cells (p Ͻ 0.01 in the 10 -1000 M concentration range of ATP). Second, chimeric receptors exhibited higher sensitivity to ATP as compared with both parental receptors, and ␣␤-meATP exhibited the full agonistic action as compared with partial agonistic action in P2X 4 R-expressing cells.
The reverse P2X 4 ϩ X 2 R chimera, having the ectodomain of P2X 2 R inserted into the backbone of P2X 4 R, was expressed at the levels comparable with those observed in experiments with P2X 2a ϩ X 4 R and P2X 2b ϩ X 4 R, as estimated by GFP fluorescence intensity. However, the receptor did not respond to ATP in the 1-1000 M concentration range. The lack of effects of ATP was not due to the endogenous desensitization of receptors because ATP was also ineffective in cells cultured in the presence of apyrase, an ectoATPase. Also, the P2X 4 ϩ X 7 R chimera having the ectodomain of P2X 7 R instead of P2X 4 R was expressed but was not functional in the presence or absence of apyrase. All together, experiments with chimeras suggested that although the ectodomain sequences we selected contained several residues critical for ligand binding, they were not sufficient to preserve intact ligand-binding domains. The P2X 4 Rspecific ligand potency was enhanced, whereas the P2X 2 R-and P2X 7 R-specific ligand potency was abolished in chimeric channels, indicating the interaction between the ectodomain and nearby residues.
Receptor-specific Desensitization Pattern-To characterize the pattern of receptor desensitization and its impact on calcium signaling, both current and calcium measurements were used. Fig. 2A illustrates typical profiles of ATP (100 M)-induced current responses in cells expressing wild-type P2X 2a R, P2X 2b R, and P2X 4 R. The peak amplitudes of current responses were in high pA (P2X 4 R) to low nA (P2X 2a R and P2X 2b R) range. Consistent with previously published data (16), P2X 2a R desensitized slowly and incompletely, reaching the steady levels with a of 22 s, whereas P2X 2b R desensitized rapidly with a calculated of about 4 s. P2X 4 R desensitized to the steady levels comparable with P2X 2b R but with a of about 9 s.
The significance of receptor-specific desensitization pattern on [Ca 2ϩ ] i response is illustrated in Fig. 2B . Three receptors generated calcium signals, which differed in profiles. The rates of signal desensitization (expressed as ) were: 96 s in P2X 2a Rexpressing cells, 18 s in P2X 2b R-expressing cells, and 45 s in P2X 4 R-expressing cells. Differences in the calculated values in current and [Ca 2ϩ ] i measurements illustrate the impact of calcium-handling mechanisms of the cells used in experiments on the rate of receptor desensitization. On the other hand, the relative ratios in the rates of P2X 2a R, P2X 2b R, and P2X 4 R desensitization estimated from two measurements were highly comparable. This clearly indicates that [Ca 2ϩ ] i measurements not only provide information about the physiological relevance of receptor activation and desensitization but also could be used as valuable parameters in characterizing the nature of P2XR desensitization, at least for slower desensitizing receptors.
A comparison between the patterns of current responses in cells expressing wild-type P2X 2a R and P2X 2b R and chimeric receptors is shown in Fig. 3 . The substitution of the native P2X 2a R ectodomain with P2X 4 ectodomain dramatically enhanced the rate of receptor desensitization (Fig. 3B) . Significant differences were also observed between P2X 2b R and P2X 2b ϩ X 4 R (Fig. 3A) . Both chimeric receptors also desensitized more rapidly than P2X 4 R (Fig. 3 versus Fig. 2 ). The same conclusion was reached in experiments with single cell calcium measurements. As shown in Fig. 4A , calcium signals desensitized more rapidly in cells expressing chimeric receptors when stimulated with 10 M ATP (upper panels) and 100 M ATP (lower panels). In parallel with changes in the EC 50 values for chimeric receptors (Fig. 1) , calcium signals also desensitized with about one log unit leftward shift in the DC 50 values as compared with parental P2X 2 Rs (Fig. 4B) . The ratios between values for current and calcium measurements in cells expressing two chimeric receptors were comparable with those observed in parental receptors. These results clearly indicate the relevance of the ectodomain structure on the kinetics of receptor desensitization and suggest that the ligand potency reflects on rate of receptor desensitization.
Current and calcium measurements showed that P2X 2b ϩX 4 R desensitized more rapidly than P2X 2a ϩX 4 R, consistent with the hypothesis that the C-terminal-specific desensitization pattern was preserved in chimeric channels. To test this hypothesis further, we generated P2X 2a-6aa ϩX 4 (15) . In accordance with these observations, P2X 2a-6aa ϩ X 4 R mutant chimera showed an increased rate of desensitization as compared with P2X 2a ϩ X 4 R chimera (Fig. 4C) , and the ratio between the rates of P2X 2a ϩ X 4 R, P2X 2a-6aa ϩ X 4 R, and P2X 2b ϩ X 4 R was comparable with that observed in cells expressing P2X 2a R, P2X 2a-6aa R, and P2X 2b R (15) . Thus, the increase in the potency of receptors for ATP increases the rates of receptor desensitization independently of the C-terminal-controlled desensitization.
Ligand-specific Desensitization Pattern-In further experiments, we compared the patterns of calcium signals and rates of desensitization in response to ATP, BzATP, and ␣␤-meATP. Fig. 5 illustrates typical profiles of calcium signals in response to these three agonists in cells expressing parental receptors. In accordance with our previous study (8) , the C-terminalspecific desensitization pattern of wild-type P2X 2 Rs observed in response to ATP (Fig. 5A, left traces) was partially mimicked by BzATP (central traces) but was lost in cells stimulated with ␣␤-meATP (right traces). The ligand specificity of receptor desensitization was also observed in cells expressing wild-type P2X 4 R (Fig. 5A, upper traces) . The mean values of the rate of receptor desensitization in response to three agonists are shown in Fig. 5B . When stimulated with ATP, three receptors desensitized with significantly different rates (left panel). No differences in the rates of P2X 2a R and P2X 4 R desensitization were observed in response to BzATP stimulation (central panel), and all three receptors desensitized with highly comparable kinetics when stimulated with ␣␤-meATP (right panel). The plateau [Ca 2ϩ ] i levels in response to three agonists also differed (illustrated by dotted lines in Fig. 5A and quantified in Table I) .
In further studies, we examined the ligand-specific desensitization pattern of chimeric receptors. Fig. 6 compares typical calcium signal profiles in cells expressing wild-type P2X 2a R and chimeric P2X 2a ϩ X 4 R (Fig. 6A ) and wild-type P2X 2b R and chimeric P2X 2b ϩ X 4 R (Fig. 6B) during the prolonged stimulation with increasing BzATP concentrations. The C-terminalspecific desensitization patterns of P2X 2a R and P2X 2b R that are present in ATP-stimulated cells (Fig. 5) , but are lost in BzATP-stimulated cells (Figs. 5 and 6 ), were reestablished in BzATP-stimulated cells expressing chimeric receptors. Fig. 6A (left panels) shows a typical pattern of receptor desensitization in wild-type and chimeric P2X 2 Rs, and bars (right panels) illustrate significant differences in the mean values for the rate of receptor desensitization, whereas Fig. 6B (left and right  panels) illustrates more dramatic differences between wildtype and chimeric P2X 2b R.
The establishment of C-terminal-specific desensitization pattern was also observed in chimeric receptors stimulated with ␣␤-meATP. Fig. 7A shows that wild-type P2X 2 Rs do not respond to 10 M ␣␤-meATP, whereas chimeric receptors do. Fig. 7B illustrates the lack of receptor-specific desensitization pattern in wild-type P2X 2 Rs and a significant difference in the rates of chimeric receptor desensitization in response to 100 M ␣␤-meATP. The same conclusions were also derived from cells stimulated with 500 M ␣␤-meATP (Fig. 7C) . Table I summarizes the level of calcium signal desensitization in wild-type and chimeric P2X 2 Rs. Thus, the introduction of the P2X 4 R ectodomain in P2X 2a R and P2X 2b R backbones had three obvious effects: increase of the rate of receptor desensitization for ATP without affecting the C-terminal-dependent desensitization pattern, reestablishment of the C-terminal-dependent receptor desensitization in response to BzATP and ␣␤-meATP stimulation, and comparable plateau levels in response to three agonists.
DISCUSSION
In this study, we used the wild-type P2X 2a R and P2X 2b R because of their identical ectodomains and rapid activation properties, but distinct and well defined desensitization patterns in response to sustained stimulation with ATP (30, 32, 33) . The P2X 4 R shares about 39% similarity with P2X 2 R and desensitizes with rates comparable with those observed in cells expressing P2X 2b R, whereas P2X 7 R shares about 26% similarity with P2X 2 R and desensitizes in a manner more comparable with the P2X 2a R subtype (6, 34) . These four receptors also exhibit highly specific ligand potency profiles, including ATP, BzATP, and ␣␤-meATP. ATP is a highly potent agonist for P2X 4 R, a high to middle potency agonist for P2X 2 R, and a low potency agonist for P2X 7 R. BzATP is considered as a high potency agonist for P2X 7 R, a middle potency agonist for P2X 2 R, and a low potency agonist for P2X 4 R. ␣␤-meATP acts as a low potency agonist for P2X 2 R and a partial agonist for P2X 4 R, whereas P2X 7 R is insensitive to this agonist (6) .
The 7 R used for construction of our chimeric channels contain the majority of residues relevant for ATP binding identified so far. They enclose the 10 conserved cysteine residues among all known P2XRs and three N-linked glycosylated sites (Asn 182 , Asn 239 , and Asn 298 in rat P2X 2 R), which might be responsible for functionality of the channels (35) (36) (37) (38) (39) . The ectodomain sequences we used also contain several conserved residues, which might contribute to the ATPbinding site, including Lys 69 and Lys 71 in rat P2X 2 sequence and corresponding to Lys 68 and Lys 70 in human P2X 1 (9, 10) , Trp 256 in rat P2X 2 (40) , and Lys 309 in human P2X 1 (9) . Because those are common residues for all seven channels, it is obvious that other residues account for ligand specificity among receptors. By exchanging the ectodomain sequences, we hoped that the ligand selectivity profiles would be preserved and thus enabled us to examine the dependence of channel activity on the ligand-binding-specific domains. In accordance with this, our previously published data with P2X 2 ϩ X 3 R chimeras having the Val 60 -Phe 301 ectodomain sequence of P2X 3 R instead of the native Ile 66 -Tyr 310 sequence showed highly comparable ligand potency with parental P2X 3 R (7, 8) .
However, the present data clearly indicate that the transfer of these ectodomains alters the native agonist selectivity and potency. First, the ATP potency for P2X 2a ϩ X 4 R and P2X 2b ϩ X 4 R chimeras was higher than that observed in both parental receptors. In parallel to that, two chimeras desensitized more rapidly than parental receptors. Second, ␣␤-meATP is a partial agonist for P2X 4 R (31) and a full and highly potent agonist for P2X 2a ϩ X 4 R and P2X 2b ϩ X 4 R chimeras. Third, P2X 4 ϩ X 2 R and P2X 4 ϩ X 7 R were expressed but were not functioning receptors. These results suggest the effects of transmembrane domain flanking sequences on ligand specificity and agonistic potency. We may speculate that these sequences act as "dominant-positive" and "dominant-negative" domains, depending on the structure of the main ectodomain sequence, to change the sensitivity of receptors for agonists. In accordance with this view, it has been reported recently that point mutations in the first transmembrane domain affect the ligand selectivity of rat P2X 2 R (41).
In this study, we also progressed in understanding the mechanism by which the putative ligand-binding domain may influence the rate of receptor desensitization and the relationship between the ectodomain and C-terminal domain in control of desensitization. The main conclusion that emerged from this work is that the P2XR desensitization pattern is receptor-and ligand-specific. The P2X 2a R-, P2X 2b R-, and P2X 4 -specific desensitization patterns were observed in response to ATP, the native agonist for these channels, but were less obvious when stimulated with BzATP and were lost when receptors were stimulated with ␣␤-meATP. The increase in EC 50 values for all three agonists induced by substituting the ectodomains indicated that the potency of agonists reflects the ligand specificity of receptor desensitization, i.e. highly potent agonists trigger the subtype-specific desensitization pattern, whereas agonists with lower potency are less effective or are ineffective. Our effort to further establish this hypothesis by generating receptors with decreasing sensitivity for ATP was unsuccessful because P2X 4 ϩ X 2 R and P2X 4 ϩ X 7 R chimeras were nonfunctional.
On the other hand, we were more successful in establishing that the ectodomain influences desensitization independently of the C-terminal domain. Earlier studies have indicated that the 6-residue receptor-specific sequences in C-terminal influence the rates of P2X 2a R, P2X 2b R, P2X 3 R, and P2X 4 R (15). In this study, current and calcium measurements indicated that chimeric P2X 2a ϩ X 4 R and P2X 2b ϩ X 4 R desensitized with different rates, i.e. a leftward shift in EC 50 and DC 50 for chimeric receptors proportionally affected both receptors. This suggests that the C-terminal-dependent desensitization pattern was not affected by substituting the ectodomains. To test this hypothesis further, we generated a mutant of P2X 2a ϩ X 4 R chimera in which we substituted the C-terminal Arg 371 -Pro 376 sequence of P2X 2a ϩ X 4 R with Glu 376 -Gly 381 sequence of P2X 4 R. In parallel to the desensitization patterns of P2X 2a R and P2X 2a-6aa R (15) , the present data show that chimeric P2X 2a-6aa ϩ X 4 R desensitized more rapidly than P2X 2a ϩ X 4 R when stimulated with ATP.
At the present time, we cannot speculate about the possible molecular mechanism by which the ligand-binding domain influences receptor desensitization. The main limitation comes from the fact that the ligand-binding domain structure and the crystal structure of P2XRs have not been identified. The structural similarities of P2XRs with class II aminoacyl-tRNA synthases (42) provided a model for initial studies on the ATPbinding domain (9, 10, 40, 41) , which could not give a rationale for the receptor behavior shown here. Based on studies with crystallization of glutamate channels, in a recently published study, Sun et al. (3) showed that desensitization of these receptors occurs through rearrangement of the dimmer interface, which disengages the agonist-induced conformation change in the binding core from the ion channel gate. To which extent this model provides a rationale for the observed effects with P2XRs is also difficult to discuss, especially with respect to data on the pattern of polymerization of these receptors (43) .
The influence of the ectodomain structure on P2XR desensitization is a novel finding for this family of receptors but is reminiscent of those seen among subtypes of other ligand-gated receptor channels. For example, AMPA and glutamate maximally activate AMPA receptors, whereas kainite and domoate act as partial agonists and produce much less desensitization than glutamate (2, 23, 24, 44) . A single amino acid mutation in the third loop of the binding pocket of the nicotinic acetylcholine receptor produces a right shift in the concentration-response curve but also significantly slows the rate of channel opening (25) . The desensitization of this receptor is affected by amino acids near or within the agonist-binding domain, as well as by residues within M2 that line the pore (26, 27) . A single residue substitution in GluR1 also gives a mutant channel that exhibits 6 -20-fold lower EC 50 values for kainate (28) . Introduction of the ␣4 residues in the agonist-binding site of nicotinic nicotinic acetylcholine receptors produces a 100-fold increase in the apparent agonist potency and desensitization of receptors and a 3-7-fold shift in the apparent affinity for activation (27) .
In conclusion, our results show that wild-type P2X 2a R, P2X 2b R, and P2X 4 R desensitized in a receptor-and ligandspecific manner. The P2X 4 R-specific ligand potency and desensitization patterns were not only transferred but were enhanced in P2X 2a ϩ X 4 R and P2X 2b ϩ X 4 R, whereas the P2X 2 R and P2X 7 R ectodomains and the backbone of P2X 4 R generated nonfunctional channels. This suggests that flanking sequences around the transmembrane domains may act as modulatory regions. A parallelism in the leftward shift of EC 50 and DC 50 for ATP further suggests that the potency of agonists underlines the ligand-specific patterns of receptor desensitization.
